Education
About Us
Working with TipRanks
Follow Us
Geratherm Medical (DE:GME)
:GME
Total Valuation
Geratherm Medical has a market cap or net worth of €17.37M. The enterprise value is ―.
Market Cap€17.37M
Enterprise Value―
Share Statistics
Geratherm Medical has 5,444,998 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,444,998
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Geratherm Medical’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 7.21%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)7.21%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee124.59K
Profits Per Employee6.21K
Employee Count179
Asset Turnover0.62
Inventory Turnover1.56
Valuation Ratios
The current PE Ratio of Geratherm Medical is 26.30. Geratherm Medical’s PEG ratio is 1.39.
PE Ratio26.30
PS Ratio0.00
PB Ratio0.73
Price to Fair Value1.31
Price to FCF-76.84
Price to Operating Cash Flow11.38
PEG Ratio1.39
Income Statement
In the last 12 months, Geratherm Medical had revenue of 22.30M and earned 1.11M in profits. Earnings per share was 0.21.
Revenue22.30M
Gross Profit7.62M
Operating Income2.22M
Pretax Income2.31M
Net Income1.11M
EBITDA4.18M
Earnings Per Share (EPS)0.21
Cash Flow
In the last 12 months, operating cash flow was 1.47M and capital expenditures -758.00K, giving a free cash flow of 714.00K billion.
Operating Cash Flow1.47M
Free Cash Flow714.00K
Free Cash Flow per Share0.13
Dividends & Yields
Geratherm Medical pays an annual dividend of €0.1, resulting in a dividend yield of 3.17%
Dividend Per Share€0.1
Dividend Yield3.17%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.35
52-Week Price Change-25.34%
50-Day Moving Average3.23
200-Day Moving Average3.64
Relative Strength Index (RSI)55.33
Average Volume (3m)1.58K
Important Dates
Geratherm Medical upcoming earnings date is Apr 25, 2024, TBA Not Confirmed.
Last Earnings DateNov 23, 2023
Next Earnings DateApr 25, 2024
Ex-Dividend DateAug 19, 2024
Financial Position
Geratherm Medical as a current ratio of 2.93, with Debt / Equity ratio of 32.38%
Current Ratio2.93
Quick Ratio1.61
Debt to Market Cap0.36
Net Debt to EBITDA0.48
Interest Coverage Ratio20.83
Taxes
In the past 12 months, Geratherm Medical has paid 645.36K in taxes.
Income Tax645.36K
Effective Tax Rate0.28
Enterprise Valuation
Geratherm Medical EV to EBITDA ratio is 7.46, with an EV/FCF ratio of -147.25.
EV to Sales1.40
EV to EBITDA7.46
EV to Free Cash Flow-147.25
EV to Operating Cash Flow21.82
Balance Sheet
Geratherm Medical has €7.74M in cash and marketable securities with €7.23M in debt, giving a net cash position of -€513.83K billion.
Cash & Marketable Securities€7.74M
Total Debt€7.23M
Net Cash-€513.83K
Net Cash Per Share-€0.09
Tangible Book Value Per Share€3.32
Margins
Gross margin is 34.16%, with operating margin of 14.28%, and net profit margin of 4.98%.
Gross Margin34.16%
Operating Margin14.28%
Pretax Margin10.36%
Net Profit Margin4.98%
EBITDA Margin18.76%
EBIT Margin11.10%
Analyst Forecast
The average price target for Geratherm Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―